Developer docs
API playgroundTry for free, no card

Search company profiles

Mint Pharmaceuticals

Full company profile

uuid0005pua

Namestring
Mint Pharmaceuticals
Legal namestring
Mint Pharmaceuticals Inc.
Company typeenum
Private
Founded yearint
2007
Short descriptiontext

Mint Pharmaceuticals Inc., founded 2007, is a privately held Canadian generic pharmaceutical company headquartered in Mississauga. With 51-100 employees, it distributes generic medicines via an active product catalog, serving Canadian healthcare channels with bilingual English/French market positioning.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMississauga, Canada
HQ citystring
Mississauga
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, pharmaceutical manufacturing, generic drug products, pharmaceutical distribution, Canadian pharmaceuticals
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals
Social media profiles2 records
Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mint Pharmaceuticals is a generic pharmaceutical company that manufactures and distributes generic drug products from its base in Mississauga, Ontario, Canada. Founded in 2007, the company supplies generic pharmaceutical formulations to the Canadian healthcare market through institutional channels. Its product catalog is accessible via its corporate website.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Generic Pharmaceutical Product Catalog
CategoryGeneric Pharmaceuticals
No data
Peers10 records
TypeDirect peer
Description

Canada's largest generic pharmaceutical manufacturer, headquartered in Toronto. Closely comparable to Mint Pharmaceuticals by product category (generic finished dosage forms), regulatory framework (Health Canada), customer base (Canadian pharmacies and provincial formularies), and manufacturing footprint in the Greater Toronto Area.

TypeDirect peer
Description

Privately held Canadian generic pharmaceutical manufacturer based in Montreal. Comparable as a privately owned Canadian generic pharma serving both English and French markets, with a similar product mix of generic prescription and OTC medicines distributed nationally.

TypeBroad incumbent
Description

Canadian subsidiary of Teva Pharmaceutical Industries, one of the world's largest generic drug producers. Comparable in product category and Canadian retail/pharmacy channel distribution, though significantly larger and operating as part of a global portfolio.

TypeBroad incumbent
Description

Canadian generics arm of Novartis (now being spun off as an independent global generics leader). Comparable in generic product portfolio and Canadian distribution channels, with much broader scale and an international parent.

TypeDirect peer
Description

Privately held Canadian generic pharmaceutical manufacturer with a national distribution network. Comparable to Mint as a Canada-focused generics company selling through retail and institutional pharmacy channels, with similar mid-sized operational profile.

TypeDirect peer
Description

Canadian generic pharmaceutical distributor and manufacturer offering a broad portfolio of generic Rx and OTC products. Comparable to Mint by product category, Canadian market focus, and operating model serving national pharmacy chains.

TypeDirect peer
Description

Quebec-based generic pharmaceutical manufacturer focused on the Canadian market. Comparable to Mint as a domestically oriented Canadian generic manufacturer, with particular strength in the Quebec market that overlaps with Mint's bilingual footprint.

8Auro Pharma Canada
TypeBroad incumbent
Description

Canadian arm of India's Aurobindo Pharma. Comparable in generic product offerings and Canadian retail/pharmacy distribution, though it operates as part of a much larger global generics platform.

TypeDirect peer
Description

Canadian generic pharmaceutical company with manufacturing and distribution operations. Comparable to Mint as a Canadian-headquartered generic pharma with overlapping product categories and channel relationships.

TypeBroad incumbent
Description

Generic specialty pharmaceutical manufacturer with historical Canadian-Israeli roots and a strong North American generics presence. Comparable in generic product portfolio and North American distribution, though significantly larger and now part of Sun Pharma.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mint Pharmaceuticals

Generic Pharmaceuticalsmintpharmaceuticals.com

Mint Pharmaceuticals Inc., founded 2007, is a privately held Canadian generic pharmaceutical company headquartered in Mississauga. With 51-100 employees, it distributes generic medicines via an active product catalog, serving Canadian healthcare channels with bilingual English/French market positioning.

Mint Pharmaceuticals firmographics

Firmographics
Name
Mint Pharmaceuticals
Legal name
Mint Pharmaceuticals Inc.
Website
https://mintpharmaceuticals.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Short description
Mint Pharmaceuticals Inc., founded 2007, is a privately held Canadian generic pharmaceutical company headquartered in Mississauga. With 51-100 employees, it distributes generic medicines via an active product catalog, serving Canadian healthcare channels with bilingual English/French market positioning.
Ownership category
akta.pro rank

Where Mint Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Mississauga
HQ country
Canada
HQ region
North America

Markets served

Mint Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Mint Pharmaceuticals product offering

Product offering

Core offering

Mint Pharmaceuticals is a generic pharmaceutical company that manufactures and distributes generic drug products from its base in Mississauga, Ontario, Canada. Founded in 2007, the company supplies generic pharmaceutical formulations to the Canadian healthcare market through institutional channels. Its product catalog is accessible via its corporate website.

Differentiator

Problem solved

Functional benefit

Products and services

  • Generic Pharmaceutical Product Catalog

Companies that use Mint Pharmaceuticals

Customer profile

Ideal customer profiles1 record

Mint Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mint Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Apotex Inc. Canada's largest generic pharmaceutical manufacturer, headquartered in Toronto. Closely comparable to Mint Pharmaceuticals by product category (generic finished dosage forms), regulatory framework (Health Canada), customer base (Canadian pharmacies and provincial formularies), and manufacturing footprint in the Greater Toronto Area.
  • Pharmascience Inc. Privately held Canadian generic pharmaceutical manufacturer based in Montreal. Comparable as a privately owned Canadian generic pharma serving both English and French markets, with a similar product mix of generic prescription and OTC medicines distributed nationally.
  • Jamp Pharma Group: Privately held Canadian generic pharmaceutical manufacturer with a national distribution network. Comparable to Mint as a Canada-focused generics company selling through retail and institutional pharmacy channels, with similar mid-sized operational profile.
  • Sanis Health: Canadian generic pharmaceutical distributor and manufacturer offering a broad portfolio of generic Rx and OTC products. Comparable to Mint by product category, Canadian market focus, and operating model serving national pharmacy chains.
  • Pro Doc Ltée: Quebec-based generic pharmaceutical manufacturer focused on the Canadian market. Comparable to Mint as a domestically oriented Canadian generic manufacturer, with particular strength in the Quebec market that overlaps with Mint's bilingual footprint.
  • Marcan Pharmaceuticals: Canadian generic pharmaceutical company with manufacturing and distribution operations. Comparable to Mint as a Canadian-headquartered generic pharma with overlapping product categories and channel relationships.

Broad incumbents

  • Teva Canada: Canadian subsidiary of Teva Pharmaceutical Industries, one of the world's largest generic drug producers. Comparable in product category and Canadian retail/pharmacy channel distribution, though significantly larger and operating as part of a global portfolio.
  • Sandoz Canada: Canadian generics arm of Novartis (now being spun off as an independent global generics leader). Comparable in generic product portfolio and Canadian distribution channels, with much broader scale and an international parent.
  • Auro Pharma Canada: Canadian arm of India's Aurobindo Pharma. Comparable in generic product offerings and Canadian retail/pharmacy distribution, though it operates as part of a much larger global generics platform.
  • Taro Pharmaceutical Industries: Generic specialty pharmaceutical manufacturer with historical Canadian-Israeli roots and a strong North American generics presence. Comparable in generic product portfolio and North American distribution, though significantly larger and now part of Sun Pharma.

Market position

Customer concentration

Mint Pharmaceuticals social profiles

Digital presence

Mint Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mint Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Mint Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mint Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mint Pharmaceuticals

What does Mint Pharmaceuticals do?

Mint Pharmaceuticals is a generic pharmaceutical company that manufactures and distributes generic drug products from its base in Mississauga, Ontario, Canada. Founded in 2007, the company supplies generic pharmaceutical formulations to the Canadian healthcare market through institutional channels. Its product catalog is accessible via its corporate website.

Is Mint Pharmaceuticals a public or private company?

Mint Pharmaceuticals is a private company. It is classified as unknown and is currently operating.

When was Mint Pharmaceuticals founded?

Mint Pharmaceuticals was founded in 2007. It employs 51 to 100 people.

Where is Mint Pharmaceuticals based?

Mint Pharmaceuticals is headquartered in Mississauga, Canada, in the North America region.

Who are Mint Pharmaceuticals's main competitors?

Direct peers on record are Apotex Inc., Pharmascience Inc., Jamp Pharma Group, Sanis Health, Pro Doc Ltée and Marcan Pharmaceuticals. Broad incumbents are Teva Canada, Sandoz Canada, Auro Pharma Canada and Taro Pharmaceutical Industries.

Does Mint Pharmaceuticals have an API?

No public API is recorded for Mint Pharmaceuticals.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooMint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in CanadaMint Pharmaceuticals and Bayer expanded their Canadian distribution partnership to include ANGELIQ, CLIMARA, TRIQUILAR, and XARELTO, building on their existing collaboration for ADALAT XL. The expansion aims to maintain supply continuity across cardiovascular and women's health portfolios.PR NewswireMint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in CanadaMint Pharmaceuticals expanded its distribution partnership with Bayer to include ANGELIQ, CLIMARA, TRIQUILAR, and XARELTO in Canada. The expansion builds on the existing relationship for ADALAT XL and aims to maintain supply continuity across the portfolio.PR NewswireMint Pharmaceuticals Announces Partnership with Bayer Canada to Distribute ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in CanadaMint Pharmaceuticals Inc. announced a new partnership with Bayer Canada for the distribution of ADALAT® XL® 30 mg tablets in Canada, effective September 3, 2025. The collaboration aims to enhance the accessibility and availability of the medication, which is indicated for managing chronic stable angina and mild to moderate essential hypertension, to healthcare providers and patients across Canada. Both companies stated the partnership will leverage Mint's extensive distribution network and expertise to ensure timely availability of the therapy.MorningstarMint Pharmaceuticals Announces Partnership with Bayer Canada to Distribute ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in CanadaMint Pharmaceuticals announced a partnership with Bayer Canada to distribute ADALAT XL 30 mg tablets in Canada, effective September 3, 2025. The drug, indicated for chronic stable angina and mild to moderate hypertension, aims to enhance accessibility. Mint's supply chain has averted 23 national drug shortages in the past decade.YahooMint Pharmaceuticals Announces Partnership with Bayer Canada to Distribute ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in CanadaMint Pharmaceuticals announced a new partnership with Bayer Canada for the distribution of ADALAT® XL® 30 mg tablets in Canada, effective September 3, 2025. The collaboration aims to leverage Mint's distribution network and expertise in the Canadian market to enhance accessibility of the medication, which is indicated for managing chronic stable angina and mild to moderate essential hypertension. Both companies stated that the partnership reinforces their shared commitment to reliability, quality, and patient care in ensuring timely availability of the therapy.